Identifying Treatments for Stage C2 Heart Failure.
Publication
, Journal Article
Yancy, CW; Hernandez, AF; Fonarow, GC
Published in: JAMA Cardiol
January 1, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
January 1, 2022
Volume
7
Issue
1
Start / End Page
34 / 35
Location
United States
Related Subject Headings
- Humans
- Heart Failure
- Cyclosporine
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Yancy, C. W., Hernandez, A. F., & Fonarow, G. C. (2022). Identifying Treatments for Stage C2 Heart Failure. JAMA Cardiol, 7(1), 34–35. https://doi.org/10.1001/jamacardio.2021.4024
Yancy, Clyde W., Adrian F. Hernandez, and Gregg C. Fonarow. “Identifying Treatments for Stage C2 Heart Failure.” JAMA Cardiol 7, no. 1 (January 1, 2022): 34–35. https://doi.org/10.1001/jamacardio.2021.4024.
Yancy CW, Hernandez AF, Fonarow GC. Identifying Treatments for Stage C2 Heart Failure. JAMA Cardiol. 2022 Jan 1;7(1):34–5.
Yancy, Clyde W., et al. “Identifying Treatments for Stage C2 Heart Failure.” JAMA Cardiol, vol. 7, no. 1, Jan. 2022, pp. 34–35. Pubmed, doi:10.1001/jamacardio.2021.4024.
Yancy CW, Hernandez AF, Fonarow GC. Identifying Treatments for Stage C2 Heart Failure. JAMA Cardiol. 2022 Jan 1;7(1):34–35.
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
January 1, 2022
Volume
7
Issue
1
Start / End Page
34 / 35
Location
United States
Related Subject Headings
- Humans
- Heart Failure
- Cyclosporine
- 3201 Cardiovascular medicine and haematology